ArticleBMC cancer2021
A novel scoring system integrating molecular abnormalities with IPSS-R can improve the risk stratification in patients with MDS.
Siyu Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it